Commonly mutated gene shown to drive therapeutic resistance in HER2-positive breast cancer
Older adults with advanced bladder cancer prioritize honest information about what to expect
8 July 2022US abortion ruling threatens access to arthritis drug
8 July 2022Commonly mutated gene shown to drive therapeutic resistance in HER2-positive breast cancer
PIK3CA is a gene that makes an enzyme called PI3K, which is involved in many important cell functions. When PIK3CA mutates, however, it can make the PI3K enzyme become overactive and cause cancer cells to grow.
